BRIEF-Eiger completes enrollment in phase 2 limt hdv study
July 24, 2017 at 08:30 AM EDT
* Eiger completes enrollment in Phase 2 LIMT HDV study of pegylated interferon lambda in Hepatitis Delta Virus infection
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|